Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
VANCOUVER – Angiotech Pharmaceuticals, Inc., a Vancouver-based company that was formerly a major player in Canada’s biotechnology sector, has agreed to sell certain assets for $362.5 million in cash to Argon Medical Devices, Inc. Angiotech says the funds will be used repay all its outstanding debt. Angiotech’s stock was delisted from the Toronto and Nasdaq markets in early 2011 during a court-supervised restructuring. Previously, the company had commercial success with a process used in making devices for angioplasty heart surgeries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.